18001200365

+91-9654860915

Google 4.8

For Know More about NPP Log In

Home About Us Named Patient Program

Category Page

Report Adverse Temp & Logistic Medicine Safety Why Prescription

News Article Events

News Article Events

Contact Us

Request With Prescription

Home
FDA Drug Approvals
Gavreto

Gavreto

Indian Pharma Network Footer

Transforming Patient’s Lives Through Networking

If you have any questions or need assistance, our team is here to help you at every step of your medicine access journey.

Our team is available Monday to Friday, from 9:00 AM to 6:00 PM

NPP

Named

Patient

Program

We support access to essential, life-saving medicines that are approved in global markets but may not yet be available in your country. Through regulated Named Patient import pathways, we help patients and healthcare providers access critical therapies when they are needed most.

Quick Links

About Us Contact Us Legal & Complience Named Patient
Program Resources Therapeutic Area

Imported Medicines

Blincyto in India Braftovi in India Imdeltra In India Kineret in India Krazati in India Lazcluze in india Lytgobi in India Orencia in India Retevmo in India Trientine Availability Trientine in India Trodelvy in India Vyloy in India Welireg in India

Best Treatment

Acute Myeloid Leukemia Bladder Cancer Brain Tumor Breast Cancer Cervical Cancer Colorectal Cancer Kidney cancer Lung Cancer Muscular Dystrophy Ovarian Cancer Prostate Cancer Rheumatoid Arthritis Thyroid cancer Wilson's Disease

Top Articles

AHUS Counterfeit Drugs Eculizumab HMPV Melanoma MPOX Virus Nelarabine PAH PBC PNH Polivy Trodelvy

FDA Drug Approvals

Alyftrek Brynovin Datroway Gavreto Gomekli Grafapex Lumakras Symbravo

Latest News

FDA Approves Qfitlia (Fitusiran) for Hemophilia Manufacture Risdiplam for (SMA) Takeda's Qdenga Vaccine Trusted Global Supplier from India Wilson's Disease: Neurological Symptoms, Early Signs, and Treatment Options

Quick Links

About Us Contact Us Legal & Complience Named Patient
Program Resources Therapeutic Area

Imported Medicines

Blincyto in India Braftovi in India Imdeltra In India Kineret in India Krazati in India Lazcluze in india Lytgobi in India Orencia in India Retevmo in India Trientine Availability Trientine in India Trodelvy in India Vyloy in India Welireg in India

Best Treatment

Acute Myeloid Leukemia Bladder Cancer Brain Tumor Breast Cancer Cervical Cancer Colorectal Cancer Kidney cancer Lung Cancer Muscular Dystrophy Ovarian Cancer Prostate Cancer Rheumatoid Arthritis Thyroid cancer Wilson's Disease

Top Articles

AHUS Counterfeit Drugs Eculizumab HMPV Melanoma MPOX Virus Nelarabine PAH PBC PNH Polivy Trodelvy

FDA Drug Approvals

Alyftrek Brynovin Datroway Gavreto Gomekli Grafapex Lumakras Symbravo

Latest News

FDA Approves Qfitlia (Fitusiran) for Hemophilia Manufacture Risdiplam for (SMA) Takeda's Qdenga Vaccine Trusted Global Supplier from India Wilson's Disease: Neurological Symptoms, Early Signs, and Treatment Options

NAMED PATIENT PROGRAM

Indian Pharma Network Tower A 905, I-Thum Business Park, Block A, Sector 62, Noida, Uttar Pradesh 201301

HELP AND SUPPORT

+91 9654860915

18001200365

CONTACT US

info@namedpatientprogram.com

Medicines facilitated via patient access pathways are made available solely upon receipt of a valid prescription and in accordance with all applicable regulatory frameworks.

Terms and Condition Privacy Policy Cookies Settings Sitemap

Disclaimer: Disclaimer: The website namedpatientprogram.com facilitates access to prescribed medicines through regulated sourcing channels, including manufacturers and duly authorized distributors. The company does not manufacture, formulate, or modify any pharmaceutical products. All trademarks, brand names, and product names mentioned are the property of their respective owners. Their use is solely for identification purposes and in accordance with applicable trademark laws, including the Trade Marks Act, 1999, under principles of fair use. The company does not claim ownership of, nor assert any rights over, any patents associated with the products referenced. Responsibility for compliance with applicable patent laws, including the Patents Act, 1970, rests solely with the respective patent holders, manufacturers, or marketing authorization holders. The company facilitates access to certain medicines that may not yet be approved or commercially available in a patient’s country, including recently approved or newly introduced therapies, through legally permissible channels such as named patient programs. Such access is strictly subject to a valid prescription from a licensed medical practitioner and full compliance with applicable laws and regulatory requirements. Nothing contained herein shall be construed as an inducement or authorization to infringe any intellectual property rights.

Copyright © 2026 Named Patient Programs.

Cookies are small text files stored on your device when you visit a website. They help websites function smoothly, improve performance, and provide insights into how users interact with digital services.